Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus

NCT02097342 ↗

Phase 4 Unknown 30 enrolled Post Graduate Institute of Medical Education and Research, Chandigarh

RandomizedParallel-groupTriple-blindTreatment

Summary

This study is planned to evaluate if linagliptin can improve insulin sensitivity in patients with type 2 diabetes mellitus. In addition, the effect of linagliptin on pancreatic function will be studied.

Timeline

Start: 2013-12
Primary completion: 2014-11
Completion: 2015-01

Publications

Parthan G, Bhansali S, Kurpad AV, Walia R, Bhat K, Bhansali A. Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial. BMC Pharmacol Toxicol. 2018 Jul 3;19(1):38. doi: 10.1186/s40360-018-0228-z.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Linagliptin	Small molecule	5 mg	Oral
Comparator	Voglibose	Small molecule	0.2 mg	Oral

Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus

Summary

Timeline

Publications

Drugs

Indications